LYNSEY LAKIN: Open Payments
NPI 1861890030 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210,155 in 486 payments from 27 companies in 2025. Trend: 2023 $54,401 · 2024 $154,404 · 2025 $210,155
Speaker / faculty: $143,449Travel & lodging: $37,487Food & beverage: $11,393Consulting: $10,370Honoraria: $4,956Grant: $2,500
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 131 | $116,487 |
| Genentech USA, Inc. | 52 | $18,239 |
| Biogen, Inc. | 44 | $13,494 |
| UCB, Inc. | 55 | $13,338 |
| TG Therapeutics, Inc. | 20 | $10,028 |
| Novartis Pharmaceuticals Corporation | 35 | $7,409 |
| GENZYME CORPORATION | 11 | $6,805 |
| ANI Pharmaceuticals, Inc. | 21 | $6,504 |
| ABBVIE INC. | 26 | $6,215 |
| PFIZER INC. | 14 | $5,613 |
Products named: Mavenclad, Ocrevus, Rystiggo, BRIUMVI, TYSABRI, PURIFIED CORTROPHIN GEL, KESIMPTA, UBRELVY.
Industry payments across CA — which companies pay providers there.
